Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Novo Nordisk discontinues inflammatory research

Country: Denmark

Novo Nordisk A/S said it is discontinuing its research into inflammatory diseases following the termination of its anti-interleukin-20 treatment for rheumatoid arthritis, which was its most advanced drug candidate in the field.

Read more

Novartis plans filings for heart drug

Country: Switzerland

Novartis is planning regulatory submissions in both the US and Europe for a new heart drug in the wake of trial results showing the drug's superior performance to enalapril, a standard treatment for hypertension and heart failure.

Read more

ThromboGenics provides first half update

Country: Belgium

Read more

Product revenue boosts Nicox in H1

Country: France

Read more

Ablynx strengthens cash position

Country: Belgium

Read more

ArGEN-X gives clinical update

Country: Belgium

Read more

Medtronic purchases Dutch brain-stimulation company

Country: United States

Read more

J&J affiliate unit buys Swiss antibody firm

Country: United Kingdom

Read more

Japanese stem cell scientist dies

Country: Japan

Read more

FDA comments on mesenchymal stem cells

Country: United States

Read more

Gene therapy acquisition

Country: Netherlands

Read more

Malaria protein described

Country: Denmark

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How Britain champions medical innovation

UKasBiocentreSept2014.pdf

Highlights of the September 2014 MedNous issue

The September 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    How Versant Ventures
    builds to buy
  • Research Strategy
    New targets for
    malaria vaccines
  • Public Policy
    Britain champions
    medical innovation
  • Commentary
    Getting traction against
    antimicrobial resistance
    By Dawn Firmin
  • Commentary
    Expanding medicine access
    through formulation
    By Thomas Reese Saylor

The latest MedNous journal. Subscribe to download.

Recent Appointments